Mereo Biopharma Group PLC

Active09481161 Public limited company
Incorporated
10 March 2015 (11 years)
Industry
Research and experimental development on biotechnology (72110)
Directors
Justin Roberts
Daniel Shames
Marc Yoskowitz
Controlled by
Details protected
Accounts type
Group
Region
Greater London
Address
4th Floor
One
Cavendish Place
London
W1G 0QF

Filing status

Accounts due
30 June 2027
Last accounts
31 December 2025
Conf. stmt due
9 March 2027
Last conf. stmt
23 February 2026

Charges

Total
2
Outstanding
0
Part satisfied
0
Satisfied
2

Officers 10 active

Officer details are public data from the Companies House register.

Sermon, Charles Edward
Secretary · Appointed 9 November 2023
Roberts, Justin
Director · Appointed 10 November 2022
American
Born October 1982 (44)
Shames, Daniel, Dr
Director · Appointed 10 November 2022
American
Born September 1945 (81)
Yoskowitz, Marc
Director · Appointed 10 November 2022
American
Born August 1974 (52)
Jacquet, Pierre, Dr
Director · Appointed 20 September 2021
Belgian
Born October 1966 (60)
Bender, Jeremy, Dr
Director · Appointed 1 October 2020
American
Born September 1971 (55)
Pakianathan, Deepika, Dr
Director · Appointed 23 April 2019
American
Born January 1965 (61)
Wyzga, Michael
Director · Appointed 23 April 2019
American
Born March 1955 (71)
Ekblom, Anders
Director · Appointed 21 April 2015
Swedish
Born September 1954 (72)
Director · Appointed 10 March 2015
Also at Mereo Biopharma 3 Limited, Mereo Biopharma 1 Limited, Mereo Biopharma 2 Limited · more companies
British
Born May 1959 (67)
Officer history (13 former)
14 May 2026
Resigned Jenkins, Annalisa, Dr as Director
9 November 2023
Appointed Sermon, Charles Edward as Secretary
8 November 2023
Resigned Costello, Simon James as Secretary
31 March 2023
Resigned Sermon, Charles Edward as Secretary
31 March 2023
Appointed Costello, Simon James as Secretary
10 November 2022
Appointed Jenkins, Annalisa, Dr as Director
10 November 2022
Resigned Fellner, Peter John, Dr as Director
10 November 2022
Resigned Schwartz, Brian, Dr as Director
10 November 2022
Appointed Yoskowitz, Marc as Director
10 November 2022
Appointed Shames, Daniel, Dr as Director
10 November 2022
Appointed Roberts, Justin as Director
10 November 2022
Resigned Mullick, Abdul Hafeez, Dr as Director
10 November 2022
Resigned Hyland, Anne Philomena as Director
17 May 2022
Appointed Mullick, Abdul Hafeez, Dr as Director
1 March 2022
Appointed Hyland, Anne Philomena as Director
26 October 2021
Resigned Kashyap, Kunal as Director
20 September 2021
Resigned Bains, Peter James Jonathan as Director
20 September 2021
Appointed Jacquet, Pierre, Dr as Director
1 October 2020
Appointed Schwartz, Brian, Dr as Director
1 October 2020
Appointed Bender, Jeremy, Dr as Director
1 October 2020
Resigned Blackburn, Paul as Director
29 June 2020
Resigned Jones, Richard Crispin as Director
23 April 2019
Appointed Wyzga, Michael as Director
23 April 2019
Appointed Pakianathan, Deepika, Dr as Director
8 February 2019
Resigned Armstrong, Frank Murdoch as Director
30 January 2017
Appointed Jones, Richard Crispin as Director
1 November 2016
Resigned Bungay, Richard Edward as Director
9 June 2016
Appointed Bungay, Richard Edward as Director
6 October 2015
Appointed Blackburn, Paul as Director
29 July 2015
Appointed Fellner, Peter John, Dr as Director
19 May 2015
Appointed Sermon, Charles Edward as Secretary
21 April 2015
Appointed Ekblom, Anders as Director
21 April 2015
Appointed Armstrong, Frank Murdoch as Director
21 April 2015
Appointed Bains, Peter James Jonathan as Director
21 April 2015
Appointed Kashyap, Kunal as Director
10 March 2015
Appointed Scots-Knight, Denise Vera, Dr as Director

Ownership 1 active

People and entities with significant control, from the Companies House PSC register

Details protected
Exemptions

Holdings 4

Companies where Mereo Biopharma Group PLC is registered as a person with significant control

Owns 75–100% of shares
Active
Owns 75–100% of shares
Active
Owns 75–100% of shares
Active
Owns 75–100% of shares
Active
Former controllers (2)
15 October 2019
Ceased Woodford Investment Management Limited — Owns 25–50% of shares
23 April 2019
Ceased Invesco Asset Management Limited — Owns 25–50% of shares

Filings

Recent filings only. See the full history on Companies House

DateDescriptionMade Up ToPagesPDF
29 July 2026Statement of capital following an allotment of shares
1 June 2026Resolutions
27 May 2026Termination of appointment of a director
26 May 2026Confirmation statement with updates23 February 2026
20 May 2026Group of companies' accounts31 December 2025
Show all recent filings

Some other companies at this address

Mereo Biopharma 1 Limited
Mereo Biopharma 2 Limited
Mereo Biopharma 3 Limited
Mereo Biopharma 4 Limited

Other companies in this industry

Oxford
Sandwich
Newcastle Upon Tyne
London
London
Edinburgh

By trade and location

New companies in London →

Explore the largest companies

Largest companies in London, UK →

Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →

← Back to companies Official record on Companies House ↗

Already have an account?

Create your account

Save searches and get the weekly email of new matches.

First name is required.
Last name is required.
Enter an email address like name@example.com.
Must be at least 8 characters. Password must be at least 8 characters.

Already have an account?